Leading the way in life science technologies
FEEDBURNER Genetics
Genetic Engineering & Biotechnology News (GEN) is the flagship publication of Mary Ann Liebert, Inc., celebrating its 40th anniversary in 2021. Renowned for its comprehensive coverage, GEN delivers exclusive insights and analysis across the life sciences, focusing on areas such as drug discovery, bioprocessing, OMICS, translational medicine, and gene editing. The magazine features high-quality reporting on the latest industry news, cutting-edge tools, and scientific advancements, making it an indispensable resource for researchers and executives.
-
Parabilis Files for IPO, a Day After Signing Up-to-$2.3B Regeneron Collaboration
-
Enzymes Involved in Cholesterol Transport May Point to New Cancer Therapies
-
Skape Bio Unlocks Generalizable GPCR Drugs Using AI Protein Design
-
Human Gut Organoids with Functional Nerves Developed that Can Be Mass Produced
-
AI Scientists, Stock Tumble, Patent Lawsuit, and New Partnerships
EN
MT
DE
FR
ES
IT